Sharifi Hooman, Masjedi Mohammad Reza, Emami Habib, Ghanei Mostafa, Eslaminejad Alireza, Radmand Golnar, Buist A Sonia
Tobacco Prevention and Control Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tanaffos. 2014;13(3):6-13.
Chronic Obstructive Pulmonary Diseases (COPD) is estimated to rank fifth in burden of disease and third in terms of mortality by 2020 worldwide. It is characterized by chronic inflammation and non-fully reversible airflow obstruction, causing structural changes in the lungs that can be demonstrated by a post bronchodilator FEV1/FVC ratio <70%.
The sampling frame of the current study was the population of Tehran, the capital of Iran with the current population of nearly 8.1 million. A stratified cluster sampling strategy with proportional allocation within strata was used in this study. The target population was all Tehran residents, aged 18 to 40 in one group and over 40 in another, in the year 2013. The stratification process of the sample according to the 22 municipal districts of Tehran city has been incorporated in the sampling process. Proportional to the number of households in the 22 districts, the appropriate number of clusters is weighted according to each district. The decision about the number of clusters is based on total sample size; mean household members; and logistical facilities for subject enumeration, transport, and examination.
The overall COPD prevalence defined by the spirometric functional criteria was 10%, higher in men 12 (11.9%) than in women 15 (8.8%); the prevalence was significantly higher in subjects aged over 55 years (P =0.001). Only 10(3.7%) of these COPD patients had already been diagnosed by a physician. Of all subjects fulfilling the criteria for COPD according to the Burden of Obstructive Lung Disease (BOLD) guidelines (post bronchodilator FEV1/FVC<70%), 90(33.3%) had chronic productive cough, and 262(96.7%) had either long-standing cough, sputum production, recurrent wheeze, dyspnea, or attacks of shortness of breath.
Due to the small sample size at this stage of project, conclusions should be drawn with caution. In this first epidemiological report in Tehran about COPD, a moderate prevalence of the disease was determined, and a high percentage of this figure had not been diagnosed before by a physician.
据估计,到2020年,慢性阻塞性肺疾病(COPD)在全球疾病负担中排名第五,在死亡率方面排名第三。其特征为慢性炎症和不完全可逆的气流阻塞,导致肺部结构改变,这可通过支气管扩张剂后FEV1/FVC比值<70%得以证实。
本研究的抽样框架为伊朗首都德黑兰的人口,目前人口接近810万。本研究采用分层整群抽样策略,各层内按比例分配。目标人群为2013年所有德黑兰居民,一组年龄在18至40岁之间,另一组年龄在40岁以上。根据德黑兰市的22个市政区对样本进行分层的过程已纳入抽样过程。根据22个区的家庭数量,按比例对适当数量的整群进行加权。关于整群数量的决定基于总样本量、平均家庭成员数量以及用于受试者枚举、运输和检查的后勤设施。
根据肺功能测定功能标准定义的COPD总体患病率为10%,男性患病率为12(11.9%),高于女性的15(8.8%);55岁以上受试者的患病率显著更高(P = 0.001)。这些COPD患者中只有10(3.7%)已被医生诊断。在所有根据慢性阻塞性肺疾病负担(BOLD)指南符合COPD标准(支气管扩张剂后FEV1/FVC<70%)的受试者中,90(33.3%)有慢性咳痰,262(96.7%)有长期咳嗽、咳痰、反复喘息、呼吸困难或呼吸急促发作。
由于项目现阶段样本量较小,应谨慎得出结论。在这份关于德黑兰COPD的首份流行病学报告中,确定了该疾病的中度患病率,且该数字中有很大比例此前未被医生诊断过。